國立虎尾科技大學 |

Placebos and Nocebos in Headaches

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Placebos and Nocebos in Headaches/ edited by Dimos D. Mitsikostas, Fabrizio Benedetti.
其他作者:	Mitsikostas, Dimos D.
面頁冊數:	IX, 142 p. 5 illus., 3 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Internal medicine. -
電子資源:	https://doi.org/10.1007/978-3-030-02976-0
ISBN:	9783030029760

Placebos and Nocebos in Headaches
Placebos and Nocebos in Headaches[electronic resource] /edited by Dimos D. Mitsikostas, Fabrizio Benedetti. - 1st ed. 2019. - IX, 142 p. 5 illus., 3 illus. in color.online resource. - Headache,2197-652X. - Headache,.

1 Headache Classification and Diagnosis -- 2 The burden of headache -- 3 Patient centred approach in headaches -- 4 Unmet needs in headache management -- 5 Mechanisms of pain and headache -- 6 The reward system -- 7 Mechanisms of placebo -- 8 Mechanisms of nocebo -- 9 Placebo in headache treatment -- 10 Nocebo in headache treatment. .

This book discusses the role of placebos and nocebos in the treatment of headache disorders. These disorders are usually treatable, but safety and tolerability issues mean that available preventive treatments have often limited success, even in the right hands – one in five patients treated with a migraine preventive pharmaceutical agent discontinues treatment for those reasons. The nocebo effect plays a role here, with patients’ negative expectation and previous unpleasant treatment experiences creating negative belief in the treatment’s benefits and safety, which in turn limits treatment outcomes and adherence significantly. In RCTs on migraine prevention, one in 20 patients treated with a placebo discontinued treatment because of adverse events, indicating a considerable nocebo effect; the fewer potential adverse events described in the consent form, the smaller the nocebo effect. As such, physicians treating headache sufferers should acknowledge nocebo as a significant cofactor for treatment adherence and failure, and plan techniques to limit the effects, such as patient education and close follow-up. This highly informative and painstakingly presented book provides scientific insights for professionals and scholars with an interest in internal medicine, neurology and pain medicine. .

ISBN: 9783030029760

Standard No.: 10.1007/978-3-030-02976-0doiSubjects--Topical Terms:

644638
Internal medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

Placebos and Nocebos in Headaches
LDR:02969nam a22003975i 4500 001 1008021
003 DE-He213
005 20200705122821.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030029760 $9 978-3-030-02976-0
024 7 $a 10.1007/978-3-030-02976-0 $2 doi
035 $a 978-3-030-02976-0
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
245 1 0 $a Placebos and Nocebos in Headaches $h [electronic resource] / $c edited by Dimos D. Mitsikostas, Fabrizio Benedetti.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a IX, 142 p. 5 illus., 3 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Headache, $x 2197-652X
505 0 $a 1 Headache Classification and Diagnosis -- 2 The burden of headache -- 3 Patient centred approach in headaches -- 4 Unmet needs in headache management -- 5 Mechanisms of pain and headache -- 6 The reward system -- 7 Mechanisms of placebo -- 8 Mechanisms of nocebo -- 9 Placebo in headache treatment -- 10 Nocebo in headache treatment. .
520 $a This book discusses the role of placebos and nocebos in the treatment of headache disorders. These disorders are usually treatable, but safety and tolerability issues mean that available preventive treatments have often limited success, even in the right hands – one in five patients treated with a migraine preventive pharmaceutical agent discontinues treatment for those reasons. The nocebo effect plays a role here, with patients’ negative expectation and previous unpleasant treatment experiences creating negative belief in the treatment’s benefits and safety, which in turn limits treatment outcomes and adherence significantly. In RCTs on migraine prevention, one in 20 patients treated with a placebo discontinued treatment because of adverse events, indicating a considerable nocebo effect; the fewer potential adverse events described in the consent form, the smaller the nocebo effect. As such, physicians treating headache sufferers should acknowledge nocebo as a significant cofactor for treatment adherence and failure, and plan techniques to limit the effects, such as patient education and close follow-up. This highly informative and painstakingly presented book provides scientific insights for professionals and scholars with an interest in internal medicine, neurology and pain medicine. .
650 0 $a Internal medicine. $3 644638
650 0 $a Neurology . $3 1253459
650 0 $a Pain medicine. $3 790323
650 1 4 $a Internal Medicine. $3 668583
650 2 4 $a Neurology. $3 593894
650 2 4 $a Pain Medicine. $3 669117
700 1 $a Mitsikostas, Dimos D. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1101939
700 1 $a Benedetti, Fabrizio. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1301833
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030029753
776 0 8 $i Printed edition: $z 9783030029777
830 0 $a Headache, $x 2197-652X $3 1254719
856 4 0 $u https://doi.org/10.1007/978-3-030-02976-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)